Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Webb

Showing results (371-380 of 389) with videos related to

Pageof 39
Sort By:
Nature Structural & Molecular Biology|September 15, 2020
BAK core dimers bind lipids and can be bridged by themAngus D Cowan, Nicholas A Smith, Jarrod J Sandow, et al.
Nature|December 14, 2018
Structure of Plasmodium falciparum Rh5-CyRPA-Ripr invasion complexWilson Wong, Rick Huang, Sebastien Menant, et al.
Nature Communications|June 23, 2018
Conformational switching of the pseudokinase domain promotes human MLKL tetramerization and cell death by necroptosisEmma J Petrie, Jarrod J Sandow, Annette V Jacobsen, et al.
Cell Reports|September 26, 2019
Viral MLKL Homologs Subvert Necroptotic Cell Death by Sequestering Cellular RIPK3Emma J Petrie, Jarrod J Sandow, Wil I L Lehmann, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 8, 2014
Activation of the pseudokinase MLKL unleashes the four-helix bundle domain to induce membrane localization and necroptotic cell deathJoanne M Hildebrand, Maria C Tanzer, Isabelle S Lucet, et al.
Elife|October 13, 2020
Cytotoxic T cells swarm by homotypic chemokine signallingJorge Luis Galeano Niño, Sophie V Pageon, Szun S Tay, et al.
Nature Microbiology|January 14, 2017
EspL is a bacterial cysteine protease effector that cleaves RHIM proteins to block necroptosis and inflammationJaclyn S Pearson, Cristina Giogha, Sabrina Mühlen, et al.
Nature Microbiology|February 14, 2017
Erratum: EspL is a bacterial cysteine protease effector that cleaves RHIM proteins to block necroptosis and inflammationJaclyn S Pearson, Cristina Giogha, Sabrina Mühlen, et al.
Blood Advances|October 20, 2020
Clinical MDR1 inhibitors enhance Smac-mimetic bioavailability to kill murine LSCs and improve survival in AML modelsEmma Morrish, Anthony Copeland, Donia M Moujalled, et al.
Nature|September 13, 2013
A type III effector antagonizes death receptor signalling during bacterial gut infectionJaclyn S Pearson, Cristina Giogha, Sze Ying Ong, et al.
Pageof 39

Showing results (371-380 of 389) with videos related to

Sort By:
Pageof 39
Nature Structural & Molecular Biology|September 15, 2020
BAK core dimers bind lipids and can be bridged by themAngus D Cowan, Nicholas A Smith, Jarrod J Sandow, et al.
Nature|December 14, 2018
Structure of Plasmodium falciparum Rh5-CyRPA-Ripr invasion complexWilson Wong, Rick Huang, Sebastien Menant, et al.
Nature Communications|June 23, 2018
Conformational switching of the pseudokinase domain promotes human MLKL tetramerization and cell death by necroptosisEmma J Petrie, Jarrod J Sandow, Annette V Jacobsen, et al.
Cell Reports|September 26, 2019
Viral MLKL Homologs Subvert Necroptotic Cell Death by Sequestering Cellular RIPK3Emma J Petrie, Jarrod J Sandow, Wil I L Lehmann, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 8, 2014
Activation of the pseudokinase MLKL unleashes the four-helix bundle domain to induce membrane localization and necroptotic cell deathJoanne M Hildebrand, Maria C Tanzer, Isabelle S Lucet, et al.
Elife|October 13, 2020
Cytotoxic T cells swarm by homotypic chemokine signallingJorge Luis Galeano Niño, Sophie V Pageon, Szun S Tay, et al.
Nature Microbiology|January 14, 2017
EspL is a bacterial cysteine protease effector that cleaves RHIM proteins to block necroptosis and inflammationJaclyn S Pearson, Cristina Giogha, Sabrina Mühlen, et al.
Nature Microbiology|February 14, 2017
Erratum: EspL is a bacterial cysteine protease effector that cleaves RHIM proteins to block necroptosis and inflammationJaclyn S Pearson, Cristina Giogha, Sabrina Mühlen, et al.
Blood Advances|October 20, 2020
Clinical MDR1 inhibitors enhance Smac-mimetic bioavailability to kill murine LSCs and improve survival in AML modelsEmma Morrish, Anthony Copeland, Donia M Moujalled, et al.
Nature|September 13, 2013
A type III effector antagonizes death receptor signalling during bacterial gut infectionJaclyn S Pearson, Cristina Giogha, Sze Ying Ong, et al.
Pageof 39